Industries
The motion that works for a developer tool will not work for a health system sale. We build the practice around the market, not the other way around.

Dev Tools
QC Growth is the go-to-market team for seed to Series A and B developer-tool and AI companies. Strategy, execution, GTM engineering, and operations in one embedded team that speaks developer and has actually shipped dev and open source tools.
Learn moreHealthcare
The specialized division of QC Growth, pairing a proven go-to-market sales model with deep healthcare and software business expertise, purpose-built for Seed-to-Series A founders ready to accelerate commercialization.
Learn moreDeep Tech
You’ve solved a hard problem, one that changes how humans live, build, move, or operate in the physical world. Now comes the part nobody warned you about: getting the world to buy it.
Learn moreEnterprise AI
QC Growth is the go-to-market team for seed to Series A and B B2B AI software companies. Strategy, execution, GTM engineering, and operations, in one team that speaks AI.
Learn moreWhy does QC Growth specialize by industry?
Because the motions are genuinely different. Developer tools sell bottom-up through adoption, enterprise AI has to win a technical evaluator and a budget owner at once, healthcare runs on committee trust over nine to eighteen months, and deep tech often has no category to sell into at all.
What if we are not in one of these four?
Tell us anyway. The four are where our operators have carried the bag, so that is where we say yes fastest, but the underlying model is the same for any technical B2B company at this stage.
What if we span two of them, like AI for healthcare?
Common, and it usually means one buying committee dominates. We work out which market actually signs the contract and build the motion for that one.
Do you work outside the United States?
Our clients are US-funded startups and the buyers are largely US-based, though several of the companies we work with are headquartered in Europe and Israel and selling into the US.
If you're at the inflection point, technology proven, market waiting, and the canyon between them, we should talk.